Episode Details
Back to Episodes
Key Decisions in HIV Care: Postexposure Prophylaxis
Episode 176
Published 3 years, 9 months ago
Description
In this episode, Michelle D. Collins-Ogle, MD, FAAP, FPIDS, AAHIVS, explores the data and recommendations for HIV postexposure prophylaxis (PEP).
Listen as she gives perspectives on:
- The CDC algorithm for evaluation and treatment of
potential HIV exposures - The CDC guideline preferred and alternative PEP antiretroviral therapy regimens
- Data for the use of the single-tablet regimen bictegravir/emtricitabine/tenofovir alafenamide for PEP
- Recommended laboratory monitoring with PEP
- The initiation of pre-exposure prophylaxis following a course of PEP, when appropriate
Presenter:
Michelle D. Collins-Ogle, MD, FAAP, FPIDS, AAHIVS
Assistant Professor of Pediatrics
Division of Pediatric Infectious Diseases
Pediatric and Adolescent HIV
Children’s Hospital at Montefiore
Pediatric Hospital of Albert Einstein
College of Medicine
Bronx, New York
Follow along with the slides at:
https://bit.ly/3NBVXWN
See the entire program at:
https://bit.ly/3fOl0XX
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.